| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |